RUNX2 and osteogenesis imperfecta: Results revealed a significant effect of OI type for downstream Wnt target TWIST1, inhibitory regulators SOST and DKK1, and osteoblastogenesis marker RUNX2. Additionally, a significant effect of treatment and a significant interaction between treatment and OI type was observed for SOST (Supplementary Fig. S2A).